Azelby Robert 4
4 · Terns Pharmaceuticals, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Azelby Robert
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-20+90,000→ 90,000 totalExercise: $4.13Exp: 2035-02-19→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]1/3rd of the shares subject to the option vest on the first anniversary measured from February 20, 2025 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.